Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 641Glioblastoma 573Glioma 409Neuroblastoma 174Neoplasms 125Astrocytoma 108Central Nervous System Neoplasms 105Medulloblastoma 89Breast Neoplasms 86Meningioma 84Carcinoma, Non-Small-Cell Lung 78Melanoma 77Lung Neoplasms 69Sarcoma 66Ependymoma 65Neurofibromatosis 1 63Recurrence 50Oligodendroglioma 48Neoplasm Metastasis 48Osteosarcoma 47Meningeal Carcinomatosis 46Diffuse Intrinsic Pontine Glioma 46Rhabdomyosarcoma 45Pheochromocytoma 44Paraganglioma 42Rhabdoid Tumor 41Gliosarcoma 40Sarcoma, Ewing 39Pancreatic Neoplasms 39Colorectal Neoplasms 33

Interventions

Diet, Ketogenic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug Resistant Epilepsy × CNS × 1 year × Clear all
NCT06309251 2025-09-03

Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients

Danone Nutricia SpA Società Benefit

Recruiting
100 enrolled
CNS

Autism Spectrum Disorder, Drug Resistant Epilepsy, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡